SUBSCRIBE
SUBSCRIBE
News   Policy

Intralytix Wins FDA Regulatory Clearance for Phage-Based E. coli Technology

March 16, 2011 | 
1 min read
BALTIMORE--(BUSINESS WIRE)--Intralytix, Inc. announced today that it has received regulatory clearance from the Food and Drug Administration for its phage-based EcoShield™ food safety product, effective against E. coli O157:H7.
Regulatory
MORE ON THIS TOPIC
Staying ahead of your competitors. Accelerated development of the company. Innovation vision. Customized solution. Unique skills. Red paper plane and whites. 3d render
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
October 28, 2026
 · 
4 min read
 · 
Heather McKenzie
Insights
Australia’s clinical trial advantage gains ground amid U.S. uncertainty
October 26, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
aardvark walking in the desert
FDA
FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns
October 23, 2026
 · 
3 min read
 · 
Tristan Manalac